The catheter stabilization devices market is set to reach from US$ 1,330.0 Mn in 2021 to US$ 2,392.1 Mn by 2033 projecting stable growth at a compound annual growth rate (CAGR) of 6.5% during the forecast period. Intravascular catheters are widely employed in modern day healthcare for treatment of lifestyle disorders. Significant rise in central line associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infection (CAUTI) has resulted in tremendous demand for catheter stabilization devices.
"Frequent failures associated with arterial catheters such as dislodgement, occlusion and infection drive arterial securement devices market growth"
Arterial securement devices are dominating the product segment for catheter stabilization devices market. They are widely employed for medical interventions in ICUs worldwide. The frequent failures associated with arterial catheters such as dislodgement, infection and occlusion causes an increasing demand for arterial securement devices. Central venous securement devices will register outstanding growth during the forecast period owing to its inherent features such as lack of occlusions during treatment protocols, less reinsertion, and decrease in replacement costs associated with central venous securement devices.
"Rising public health awareness related to chronic disease and increasing cases of hospital acquired infections drive the hospitals market growth"
Hospitals are reigning the end-use segment for catheter stabilization devices. Hospitals perform effective diagnosis and treatment of chronic diseases which requires the use of catheters. Increasing demand for minimally invasive surgical procedures and increasing cases of hospital acquired infections drive the hospitals market growth. Homecare settings will be growing at a steady pace during the forecast period on account of significant rise in terminally ill patients receiving chemotherapy and hemodialysis. Rehabilitating patients receiving palliative treatment frequently use catheter stabilization devices.
"Rising prevalence of lifestyle disorders and rap increase in the number of surgeries performed drive the market growth in North America"
North America in the resent scenario represents 37.2% share in the regional segment for catheter stabilization devices market. The major factors responsible for its culminating market growth are significant rise in the number of surgeries performed and rising prevalence of lifestyle disorders. Domicile of pharmaceutical companies manufacturing catheter stabilization devices such as C.R.Bard, Inc., B.Braun Melsungen AG, Medtronic, Plc etc. provide positive thrust to the market growth in North America region. Europe holds 24.8% market share majorly due to increasing cases of central line associated bloodstream infections (CLABSIs) each year and supportive regulatory scenario provided by European Medical Agency (EMA) for the manufacturing and sale of catheter stabilization devices. Asia Pacific accounts for 16% share on account of rising incidence of catheter associated urinary tract infections (CAUTIs) and significant increase in medical tourism.
Pharmaceutical companies manufacturing catheter stabilization devices are B.Braun Melsungen AG, Baxter International, Inc., C.R.Bard, Inc., ConvaTec, Inc., Centurion Medical Products Corporation, Medtronic, Plc., Merit Medical Systems, Inc., M C Johnson Company, Inc., TIDI Products, LLC and Smiths Medical, Inc.
Historical & Forecast Period
This study report represents analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Catheter Stabilization Devices market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2023-2033 |
Base Year | 2024 |
Forecast Period | 2025-2033 |
Historical Year | 2023 |
Unit | USD Million |
Segmentation | |
Product
| |
End-Use
| |
Region Segment (2023-2033; US$ Million)
|
Key questions answered in this report